GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (FRA:TUO) » Definitions » Cyclically Adjusted PS Ratio

Terumo (FRA:TUO) Cyclically Adjusted PS Ratio : 5.47 (As of Jun. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Terumo Cyclically Adjusted PS Ratio?

As of today (2024-06-21), Terumo's current share price is €15.10. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €2.76. Terumo's Cyclically Adjusted PS Ratio for today is 5.47.

The historical rank and industry rank for Terumo's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:TUO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.51   Med: 5.34   Max: 7.83
Current: 5.86

During the past years, Terumo's highest Cyclically Adjusted PS Ratio was 7.83. The lowest was 3.51. And the median was 5.34.

FRA:TUO's Cyclically Adjusted PS Ratio is ranked worse than
76.2% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:TUO: 5.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.988. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Terumo Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Terumo's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted PS Ratio Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.62 5.76 5.02 4.37 6.05

Terumo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.37 5.45 4.61 5.26 6.05

Competitive Comparison of Terumo's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.



Terumo Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Terumo's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=15.10/2.76
=5.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Terumo's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.988/107.2000*107.2000
=0.988

Current CPI (Mar. 2024) = 107.2000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.546 98.000 0.597
201409 0.563 98.500 0.613
201412 0.569 97.900 0.623
201503 0.598 97.900 0.655
201506 0.572 98.400 0.623
201509 0.601 98.500 0.654
201512 0.642 98.100 0.702
201603 0.650 97.900 0.712
201606 0.676 98.100 0.739
201609 0.678 98.000 0.742
201612 0.679 98.400 0.740
201703 0.760 98.100 0.830
201706 0.739 98.500 0.804
201709 0.728 98.800 0.790
201712 0.754 99.400 0.813
201803 0.762 99.200 0.823
201806 0.733 99.200 0.792
201809 0.714 99.900 0.766
201812 0.821 99.700 0.883
201903 0.820 99.700 0.882
201906 0.826 99.800 0.887
201909 0.862 100.100 0.923
201912 0.887 100.500 0.946
202003 0.882 100.300 0.943
202006 0.716 99.900 0.768
202009 0.807 99.900 0.866
202012 0.865 99.300 0.934
202103 0.844 99.900 0.906
202106 0.855 99.500 0.921
202109 0.882 100.100 0.945
202112 0.919 100.100 0.984
202203 0.910 101.100 0.965
202206 0.921 101.800 0.970
202209 0.962 103.100 1.000
202212 1.005 104.100 1.035
202303 0.948 104.400 0.973
202306 0.943 105.200 0.961
202309 0.972 106.200 0.981
202312 1.023 106.800 1.027
202403 0.988 107.200 0.988

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Terumo  (FRA:TUO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Terumo Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (FRA:TUO) Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (FRA:TUO) Headlines

No Headlines